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minute, and without AV block were enrolled and followed in effort
to identify the proportion diagnosed with SND and subsequently
treated. Rationale for not receiving pacemaker therapy for SND
was recorded. A multivariable logistic regression assessed the
association between baseline characteristics and probability of
receiving an implant after SND diagnosis.
Results: Patients (n = 510) enrolled from India and Bangladeshwere
more likely to be male (78%), with a mean age of 58  15 years, and
a history of Sinus brady/SND (63%) at baseline. Through 8.4  8.0
months follow-up, 369 received an SND diagnosis and 61 (17%) of
patients were implanted with a pacemaker. Insurance-related
issues (34%), physician preference for other medical management
(23%), patient not agreeing that their condition warranted implant
(22%), and physician determining patient was not indicated (19%)
were the dominant reasons for declining a pacemaker. Higher age,
female gender, and syncopal or pre-syncopal symptoms 30 days
prior to baseline visit were associated with a higher probability of
implant (Table 1).
Conclusions: In a real-world assessment in South Asia, 1 in 6
patients diagnosed with symptomatic SND receive a permanent
cardiac pacemaker with less than half of declines being related to
insurance reasons. Younger males were the least likely to receive
therapy. A process improvement initiative is warranted to improve
the diagnosis and therapy application.
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Introduction: The prevalence of ventriculoatrial (VA) conduction
varies from nearly 20% to 90%, depending on the population
studied. This ﬁgure is based on small studies done for different
arrhythmias. However, the prevalence of VA conduction in struc-
turally normal hearts has not been well documented to the best of
our knowledge.
Methods: Data was recorded in 47 consecutive adults without
structural heart disease, undergoing electrophysiological study
and ablation for tachyarrhythmias. AV nodal re-entrant tachycar-
dia was excluded. All procedures were performed under local
anesthesia in an anti-arrhythmic drug free state. The measure-
ments for this study were performed after ablation. The PR, QRS,
AH and HV intervals, atrioventricular Wenckebach point (AVWP)
and anterograde effective refractory period of atrioventricular
node (AVNERP) were measured. VA conduction was assessed; if
absent, it was retested after isoprenaline. VA Wenckebach point
(VAWP) and retrograde effective refractory period (VAERP) were
recorded in patients showing VA conduction. Age, gender, PR, AH,
HV, AVNERP and AVWP were assessed as correlates/predictors of
VA conduction. One-sided Fisher's exact test and unpaired t test
were used as necessary.
Results: The age of the patients was 37  13 years. Twenty-one
(45%) patients weremen and 26 (55%) were women. VA conduction
was present in 26 (55%) patients at baseline. Of the remaining 21
patients, 16 patients showed VA conduction after isoprenaline.
Only 5 (11%) patients failed to reveal VA conduction even after
isoprenaline. Of the variables studied, only the HV interval was
signiﬁcantly different (36.6  10.6 vs 49.2  5.8 ms, p < 0.003) in
patients with VA conduction. All parameters of patients with
baseline VA conduction and those with VA conduction only after
isoprenaline were similar, except the QRS duration which was
signiﬁcantly higher in patients with baseline VA conduction (90
 20.9 vs 80.1  8.4 ms, p < 0.05).
Conclusions: VA conduction is present in 55% of people with
structurally normal hearts. Isoprenaline enables VA conduction
in another 34% of these subjects. Age, gender and indicators of
AV conduction such as PR interval, AH, AVNERP and AVWP do
not differ whether VA conduction is present or absent. The
HV interval is longer in patients without VA conduction.
The QRS duration is more in patients with VA conduction at
baseline as compared to those with VA conduction only after
isoprenaline.





 10% of ventricular arrhythmias occurs in structurally normal
heart
 Classiﬁed into three groups:
 Outﬂow tract ventricular arrhythmia
 Idiopathic left ventricular tachycardia (ILVT)
 Automatic ventricular tachycardia
Outﬂow tract arrhythmia – Our experience 2011–2013
 Total OT-VA cases: 18
 Male:Female: 6:12
 Age: 22–63 years
 Co morbidity: HTN 6 cases
 Symptoms: Palpitation and giddiness
 ECG in SR: Normal in 15 and incomplete RBBB in 3
 ECG in VA: LBBB morphology and inferior axis and transition at
V4 – RVOT
 Clinical presentation: sustained VT-7 and PVC's and
NSVT-11
 Holter: PVC's ranges from 16,600 to 59,000/24 h (15–50%)
 Echo: LV dysfunction-5 (2 old MI)
 MRI with contrast: 6 patients – 2 ARVC
Mapping system:
 CARTO 3 system-8
 Ensite Array balloon-5
 Ensite velocity-4 and 2D-1
Table 1 – Multi-variable analysis of factors affecting
pacemaker implant probability.
Parameter OR (95% CI) p-Value
Age (per year) 1.03 (1.01, 1.06) 0.005
Female gender 2.41 (1.21, 4.79) 0.01
Contributes ﬁnancially
to household
0.58 (0.29, 1.14) 0.11
Syncope/presyncopal
symptoms 30 days prior
to baseline visit
4.35 (2.26, 8.35) <0.0001
Education (vs none formal)
Primary 0.96 (0.32, 2.86) 0.27
Secondary/High School 1.65 (0.54, 5.09) 0.38
College/Graduate 1.78 (0.59, 5.38) 0.23
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 7 2 – s 8 2S76
Site of origin:
 RVOT – 14 cases: anterseptal-11; posteroseptal-2 and free wall-1
 LVOT – 4 cases: Left coronary cusp-1 and aortomitral continuity-
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 Frequent PVC's, NSVT and sustained VT occurs even in
structurally normal heart.
 Drug refractory arrhythmias or intolerant patients can undergo
RF ablation safely.
Clinical and angiographic profile of
patients with complete heart block
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100 patients who came to the emergency department with com-
plete heart block were included in this prospective study. Com-
monest age group is above 60 years mostly males with chest pain
in 60%, shortness of breath in 30% and giddiness in 20% of patients,
43% are known hypertensives.
Blood pressure at the time of admission is 100/70 mm of Hg, heart
rate around 40%, tachypnoea 5%.
On auscultation crepts in 5% patients, creatinine levels elevated in
5%, hypokalemia in 15%, echo showed regional wall motion
abnormality in 30%. Severe and mild LV dysfunction 15% and
12% patients, good LV function in 3%. Degenerative complete heart
block seen in 34% patients, diphtheric15%, hypokalemic 15%,
dilated cardiomyopathy 2%. MI in 34% patients commonly inferior
wall MI. On Coronary angiogram RCA – 41%, LAD – 23%, LCX – 23%,
LCX and LAD 8%, Triple vessel disease – 8%. 10% patients had
cardiogenic shock and 26% died.
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Background: The head-up tilt table test (HUTT) is a widely used
method for investigation of syncope, presyncope, dizziness and
palpitations related to orthostatic intolerance and dysautonomia.
Time required for positive response has a probable relationship to
the sensitivity of neural reﬂex mechanism underlying syncope.
Multiple studies have addressed the role of this test in syncope
with regard to its diagnostic utility in terms of sensitivity and
speciﬁcity but none have focused the implication of time required
for positive response in relation to risk of recurrent syncope.
Aim:To correlateHUTT time intervalwith recurrence of syncope in
Indian population.
Methods: We evaluated 68 patients with history of syncope who
were referred to HUTT clinic. They were divided into two groups.
Group A included patients with recurrent syncope deﬁned as 3 or
more episodes of syncope and group B included those with less
than 3 episodes of syncope. We analyzed the time required for the
test to become positive in both the groups.
Results: Of the 68 patients studied, 22 (32.35%) were included in
group A and 46 (67.65%) were included in group B. HUTT was
positive in 41 patients (60.29%). The positivity rate was 100% in
group A and 41.3% in group B. Pattern of positive hemodynamic
response was predominantly type 1 (mixed response) in both
groups. Median time interval for positive response in group A
was 12.5 min (25th to 75th IQR = 10.5 to 14.0) in comparison to
30.0 min (25th to 75th IQR = 20.0 to 35.0) in group B. Using binary
logistic regression analysis, an inverse association was found
between recurrent syncope and time interval for positive response
(r = 0.282, p = 0.002) which was statistically signiﬁcant. Receiver
operating characteristics (ROC) curve showed that time interval of
less than 19.5 min had 94.5% sensitivity and 97.89% speciﬁcity for
recurrence of syncope. No patient experienced technical difﬁculty
or complications during the test.
Conclusion: HUTT time interval of less than 19.5 min predicted
recurrence of syncope. Hence can serve as an important clinical
predictor of future recurrence of syncope.
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cava stenosis
Neeraj Varyani, Cinosh Mathew, Ashwin
Paul Kooran, Rajneesh Calton *
Christian Medical College and Hospital, Ludhiana, India
Background: Temporary transvenous pacing is simple, life saving,
invasive procedure commonly performed in cath labs for treat-
ment of bradyarrhythmias, yet at timesmay presentwith difﬁculty
due to unexpected anatomical variations. We present a novel
technique for transfemoral venous pacing in cases with Inferior
Vena Cava (IVC) stenosis.
Method: A 68-year-old lady and a diagnosed case of rheumatic
heart disease and dilated cardiomyopathy with atrial ﬂutter pre-
sented with dry cough and worsening dyspnea for 7 days. Her
initial ECG showed frequent VPC's and digoxin levels were found to
be 3.4 ng/ml. Patient developed junctional bradycardia with hypo-
tension during hospital stay and temporary transvenous pacing by
femoral route was planned. RV pacing was initially attempted
using 6F and subsequently 5F pacing leads, but the temporary
pacing lead could not be negotiated beyond the D8 level which
was conﬁrmed by a contrast venogram. Then 6F armored sheath
was passed over a terumo wire into the RA and then through the
armored sheath, a 6F pacing lead was placed at the RV apex and
armored sheath was then pulled back into the IVC. Armored
sheath and pacing lead were anchored to the thigh. Procedure
was successful and uneventful and pacing lead and sheath were
removed after 4 days without complications.
Conclusions: Even after extensive search in various databases like
PUBMED, MEDLINE, EMBASE and Cochrane library, no mention of
similar technique has been described. Hence this case highlights a
successful novel technique for temporary pacing, when faced with
difﬁcult temporary pacing lead manipulation in cases of IVC ste-
nosis, in life threatening situations.
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 7 2 – s 8 2 S77
